Innophos Holdings, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided from operating activities:
Depreciation and amortization
Amortization of deferred financing charges
Deferred income tax provision
Gain on sale of building
Share-based compensation
Changes in assets and liabilities:
Contract termination fee received
Accounts receivable
Inventories
Other current assets
Accounts payable
Other current liabilities
Other long-term assets and liabilities, net
Net cash provided from operating activities
Cash flows used for investing activities:
Capital expenditures
Acquisition of businessess, net of cash acquired
Payments to Acquire Intangible Assets
Proceeds from sale leaseback
Proceeds from sale of building
Acquisition of businesses, net of cash acquired
Net cash used for investing activities

Cash flows from financing activities:
Proceeds from exercise of stock options
Long-term debt borrowings
Long-term debt repayments
Deferred financing costs
Excess tax benefits from exercise of stock options
Common stock repurchases
Taxes paid related to net share settlement of equity awards
Dividends paid
Net cash (used for) provided by financing activities
Effect of foreign exchange rate changes on cash and cash equivalents
Net change in cash
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Accrued additions to plant assets
Assets received as part of the supply agreement termination

Comments